Agios Pharmaceuticals is seeking accelerated approval from the U.S. FDA for its oral medication mitapivat for treating sickle ...

Newer oral blood thinners were linked to lower nonmajor bleeding risk than warfarin in adults with sickle cell disease, a ...

Following a reimbursement deal with Vertex, people with SCD in Germany will now have greater access to the gene-editing ...

SCD hospital care varied across New York State, with regional differences in admissions, charges, stays, and severity, a ...

If you’ve read my recent columns, you’ll know I’ve been in a really good place with my health as someone with sickle cell disease. I credit a lot of that to the work I’ve been putting in at the gym to ...

A discovery about red blood cells could have implications for sickle cell disease (SCD) and other blood disorders marked by problems with hemoglobin, the protein red blood cells use to carry oxygen ...

My sickle cell disease advocacy journey began more than a decade ago, but it has changed shape many times. I have lived through a silent phase, an angry phase, a loud phase, a tired phase, and, ...

Women with sickle cell anemia (SCA), the most common and severe form of sickle cell disease (SCD), have significantly lower ovarian reserve relative to women without SCA and with proven fertility, a ...

One of the $3 million 2026 Breakthrough Prizes — in Life Sciences — has been awarded to two researchers whose discoveries reshaped the treatment of sickle cell disease (SCD). The award from the ...

A global, late-stage clinical trial testing etavopivat in people with sickle cell disease (SCD) has hit its main goals, showing that the experimental oral therapy improved hemoglobin levels and ...